All In MedTech

FDA Clearance Tracker · P100029-S021

TRIFECTA VALVE WITH GLIDE TECHNOLOGY

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 24, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 24, 2016

Approved

Time to decision

205 days

Received Oct 2, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P100029-S021
Device name
TRIFECTA VALVE WITH GLIDE TECHNOLOGY
Applicant location
St. Paul, MN
Received
Oct 2, 2015
Decided
Apr 24, 2016
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P100029

Device type

Device class
Class III

Every decision under product code LWR

FDA's approval statement

As written in FDA's record.

Approval for the addition of the Trifecta Valve with Glide Technology (Trifecta GT).

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.